Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and… Read more
Laboratory Corporation of America Holdings (LH) - Total Assets
Latest total assets as of September 2025: $18.26 Billion USD
Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) holds total assets worth $18.26 Billion USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Laboratory Corporation of America Holdings - Total Assets Trend (1989–2024)
This chart illustrates how Laboratory Corporation of America Holdings’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Laboratory Corporation of America Holdings - Asset Composition Analysis
Current Asset Composition (December 2024)
Laboratory Corporation of America Holdings's total assets of $18.26 Billion consist of 26.2% current assets and 73.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.52 Billion | 8.3% |
| Accounts Receivable | $2.10 Billion | 11.4% |
| Inventory | $493.20 Million | 2.7% |
| Property, Plant & Equipment | $3.05 Billion | 16.6% |
| Intangible Assets | $3.49 Billion | 19.0% |
| Goodwill | $6.37 Billion | 34.7% |
Asset Composition Trend (1989–2024)
This chart illustrates how Laboratory Corporation of America Holdings's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laboratory Corporation of America Holdings's current assets represent 26.2% of total assets in 2024, a decrease from 30.8% in 1989.
- Cash Position: Cash and equivalents constituted 8.3% of total assets in 2024, down from 8.7% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is goodwill at 34.7% of total assets.
Laboratory Corporation of America Holdings Competitors by Total Assets
Key competitors of Laboratory Corporation of America Holdings based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Laboratory Corporation of America Holdings - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Laboratory Corporation of America Holdings generates 0.71x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Laboratory Corporation of America Holdings generates $ 4.06 in net profit.
Laboratory Corporation of America Holdings - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 1.44 | 1.66 |
| Quick Ratio | 1.35 | 1.30 | 1.53 |
| Cash Ratio | 0.23 | 0.44 | 0.00 |
| Working Capital | $1.45 Billion | $ 1.50 Billion | $ 2.05 Billion |
Laboratory Corporation of America Holdings - Advanced Valuation Insights
This section examines the relationship between Laboratory Corporation of America Holdings's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 1.22 |
| Asset Growth Rate (YoY) | 9.9% |
| Total Assets | $18.38 Billion |
| Market Capitalization | $22.34 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Laboratory Corporation of America Holdings's assets above their book value (1.22 x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Laboratory Corporation of America Holdings's assets grew by 9.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Laboratory Corporation of America Holdings (1989–2024)
The table below shows the annual total assets of Laboratory Corporation of America Holdings from 1989 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $18.38 Billion | +9.89% |
| 2023-12-31 | $16.73 Billion | -17.02% |
| 2022-12-31 | $20.16 Billion | -1.13% |
| 2021-12-31 | $20.39 Billion | +1.56% |
| 2020-12-31 | $20.07 Billion | +11.38% |
| 2019-12-31 | $18.02 Billion | +11.34% |
| 2018-12-31 | $16.19 Billion | -2.31% |
| 2017-12-31 | $16.57 Billion | +16.29% |
| 2016-12-31 | $14.25 Billion | -0.27% |
| 2015-12-31 | $14.29 Billion | +95.65% |
| 2014-12-31 | $7.30 Billion | +5.07% |
| 2013-12-31 | $6.95 Billion | +2.05% |
| 2012-12-31 | $6.81 Billion | +10.35% |
| 2011-12-31 | $6.17 Billion | -0.27% |
| 2010-12-31 | $6.19 Billion | +27.33% |
| 2009-12-31 | $4.86 Billion | +4.07% |
| 2008-12-31 | $4.67 Billion | +6.90% |
| 2007-12-31 | $4.37 Billion | +9.18% |
| 2006-12-31 | $4.00 Billion | +3.23% |
| 2005-12-31 | $3.88 Billion | +7.63% |
| 2004-12-31 | $3.60 Billion | +5.45% |
| 2003-12-31 | $3.41 Billion | +30.75% |
| 2002-12-31 | $2.61 Billion | +35.35% |
| 2001-12-31 | $1.93 Billion | +15.76% |
| 2000-12-31 | $1.67 Billion | +4.82% |
| 1999-12-31 | $1.59 Billion | -3.09% |
| 1998-12-31 | $1.64 Billion | -1.06% |
| 1997-12-31 | $1.66 Billion | -13.48% |
| 1996-12-31 | $1.92 Billion | +4.34% |
| 1995-12-31 | $1.84 Billion | +81.42% |
| 1994-12-31 | $1.01 Billion | +72.96% |
| 1993-12-31 | $585.50 Million | +22.64% |
| 1992-12-31 | $477.40 Million | +16.07% |
| 1991-12-31 | $411.30 Million | +9.91% |
| 1990-12-31 | $374.20 Million | +1.63% |
| 1989-12-31 | $368.20 Million | -- |